Brock Reeve is Executive Director of the Harvard Stem Cell Institute. In partnership with the Faculty Directors, he has overall responsibility for the operations and strategy of the Institute whose mission is to use stem cells, both as tools and as therapies, to understand and treat the root causes of leading degenerative diseases.
HSCI is comprised of the schools of Harvard University and all its affiliated hospitals and research institutions. Under the leadership of the Executive Committee, HSCI invests in scientific research in three main areas–seed grants, core facilities and large-scale disease programs. HSCI’s faculty membership has grown to almost 300 Principal and Affiliated Faculty. The Institute is now engaged with several leading pharmaceutical companies in joint research projects and its faculty have founded several stem cell-related startup companies and serve on leading Scientific Advisory Boards.
Brock came to this role from the commercial sector with extensive experience in both management consulting and operations for technology-based companies, with a focus on life sciences. His clients have included some of the leading pharmaceutical, biotechnology and medical device companies, and he also has had hands-on operational responsibility in product management and marketing roles in software start-ups. Brock received a BA and MPhil from Yale University and an MBA from Harvard Business School.